In cooperation with a physician from the Pulmonary Division of the Albert Einstein College of Medicine, the Foundation supported a study of seven patients age 58-67, all diagnosed with chronic, steroid drependant, life threatening, asthma. They each agreed to try an experimental therapy designed to relieve their life-threatening symptoms.

After receiving a new treatment regimen of high-dose injections of Triamcinolone, six of the seven showed marked functional improvement in their activities of daily living and independence. Their breathing improved from 25% to 93% and all were able to discontinue taking daily oral prednisone and their other asthema medications. Response durations ranged from three to 24 months. The results of this breakthrough study were accepted for publication in Lung, "Effect of High-Dose Intramuscular Triamcinolone in Older Adults with Severe, Chronic Asthma."